Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 08, 2019 at 04:06 pm
Share
GeneFerm Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 79.555 million compared to TWD 84.390 million a year ago. Operating loss was TWD 9.008 million compared to operating Income of TWD 851,000 a year ago. Net loss was TWD 8.735 million compared to net income of TWD 2.570 million a year ago. Basic loss per share was TWD 0.31 compared to basic earnings per share of TWD 0.09 a year ago. For the half year, sales was TWD 152.142 million compared to TWD 168.219 million a year ago. Operating loss was TWD 13.284 million compared to operating Income of TWD 1.853 million a year ago. Net loss was TWD 13.539 million compared to net income of TWD 3.231 million a year ago. Basic loss per share was TWD 0.49 compared to basic earnings per share of TWD 0.12 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.